Supernus Pharmaceuticals (SUPN) Net Margin Growth (3y) (2014 - 2026)
Supernus Pharmaceuticals (SUPN) Net Margin Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 948.00 |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 83.00 |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | -94.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -990.00 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | -604.00 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 1,312.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Supernus Pharmaceuticals | 2.74 Bn | 2.37 Bn | 185.39 Mn | -2,604.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2,604.00 |
| Dec 31, 2025 | -1,718.00 |
| Sep 30, 2025 | -2,447.00 |
| Jun 30, 2025 | 897.00 |
| Mar 31, 2025 | -2,470.00 |
| Dec 31, 2024 | 727.00 |
| Sep 30, 2024 | 741.00 |
| Jun 30, 2024 | -496.00 |
| Mar 31, 2024 | -425.00 |
| Dec 31, 2023 | -2,072.00 |
| Sep 30, 2023 | -3,616.00 |
| Mar 31, 2023 | -1,163.00 |
| Dec 31, 2022 | -1,774.00 |
| Sep 30, 2022 | -2,727.00 |
| Jun 30, 2022 | -2,663.00 |
| Mar 31, 2022 | -466.00 |
| Dec 31, 2021 | -2,080.00 |
| Sep 30, 2021 | -1,267.00 |
| Jun 30, 2021 | -1,409.00 |
| Mar 31, 2021 | -2,479.00 |